1. Executive Summary 2. Global - Pediatric Vaccines Market and Forecast (2010 - 2021) 3. Global - Pediatric Vaccines Market Share and Forecast (2010 - 2021) 3.1 Global Pediatric Vaccines - Disease Wise Market Share and Forecast 3.2 Global Pediatric Vaccines - Company Wise Market Share and Forecast 3.3 Companies Pediatric Vaccines - Disease Wise Sales Share and Forecast 3.3.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share and Forecast 3.3.2 Sanofi Pasteur - Pediatric Vaccines Sales Share and Forecast 3.3.3 Merck - Pediatric Vaccines Sales Share and Forecast 3.3.4 Pfizer - Pediatric Vaccines Sales Share and Forecast 3.4 Pediatric Vaccines Disease Wise Market - Company Share and Forecast 3.4.1 DTaP Pediatric Vaccines - Company Market Share and Forecast 3.4.2 Hepatitis Pediatric Vaccines - Company Market Share and Forecast 3.4.3 Meningococcal Pediatric Vaccines - Company Market Share and Forecast 3.4.4 Pneumococcal Pediatric Vaccines - Company Market Share and Forecast 3.4.5 Rotavirus Pediatric Vaccines - Company Market Share and Forecast 3.4.6 Tdap Pediatric Vaccines - Company Market Share and Forecast 3.4.7 Influenza Pediatric Vaccines - Company Market Share and Forecast 3.5 Global Pediatric Vaccines Market - Region Wise Share and Forecast 4. Global Pediatric Vaccines Market - Disease Wise Analysis 4.1 Diphtheria, Tetanus, Acellular, Pertussis (DTaP) - Pediatric Vaccines Market and Forecast (2006 - 2021) 4.2 Polio - Vaccines Market and Forecast (2006 - 2021) 4.3 Hepatitis - Pediatric Vaccines Market and Forecast (2007 - 2021) 4.4 Influenza - Pediatric Vaccines Market and Forecast (2010 - 2021) 4.5 HPV - Pediatric Vaccines Market and Forecast (2007 - 2021) 4.6 Pneumococcal - Pediatric Vaccines Market and Forecast (2010 - 2021) 4.7 Meningococcal - Pediatric Vaccines Market and Forecast (2010 - 2021) 4.8 Measles, Mumps, Rubella and Varicella (MMRV) - Pediatric Vaccines Market and Forecast (2007 - 2021) 4.9 Rotavirus - Pediatric Vaccines Market and Forecast (2006 - 2021) 4.10 Tdap - Pediatric Vaccines Market and Forecast (2010 - 2021) 5. Global Pediatric Vaccines Market - Company Analysis and Strategic Alliances 5.1 GlaxoSmithKline 5.1.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021) 5.1.2 Strategic Alliances of GlaxoSmithKline (GSK) 5.2 Sanofi Pasteur 5.2.1 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021) 5.2.2 Strategic Alliances of Sanofi Pasteur 5.3 Merck 5.3.1 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021) 5.3.2 Strategic Alliances of Merck 5.4 Novartis 5.4.1 Novartis - Pediatric Vaccines Sales (2010 - 2014) 5.4.2 Strategic Alliances of Novartis 5.5 Pfizer 5.5.1 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021) 5.5.2 Strategic Alliances of Pfizer 5.6 bioCSL (Now Seqirus) 5.6.1 bioCSL - Pediatric Vaccines Sales and Forecast (2010 - 2021) 5.6.2 Strategic Alliances of bioCSL 5.7 Medimmune (Subsidiary of AstraZeneca) 5.7.1 Medimmune - Pediatric Vaccines Sales and Forecast (2007 - 2021) 5.7.2 Strategic Alliances of Medimmune 6. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast 6.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021) 6.1.1 GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales and Forecast 6.1.2 GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales and Forecast 6.1.3 GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales and Forecast 6.1.4 GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales and Forecast 6.1.5 GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales and Forecast 6.1.6 GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales and Forecast 6.2 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021) 6.2.1 Sanofi Pasteur - DTaP Pediatric Vaccines Sales and Forecast 6.2.2 Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales and Forecast 6.2.3 Sanofi Pasteur - Tdap Pediatric Vaccines Sales and Forecast 6.2.4 Sanofi Pasteur - Influenza Pediatric Vaccines Sales and Forecast 6.3 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021) 6.3.1 Merck - Hepatitis Pediatric Vaccines Sales and Forecast 6.3.2 Merck - HPV Pediatric Vaccines Sales and Forecast 6.3.3 Merck - MMRV Pediatric Vaccines Sales and Forecast 6.3.4 Merck - Pneumococcal Pediatric Vaccines Sales and Forecast 6.3.5 Merck - Rotavirus Pediatric Vaccines Sales and Forecast 6.4 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021) 6.4.1 Pfizer - Pneumococcal Pediatric Vaccines Sales and Forecast 6.4.2 Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast 6.5 Novartis - Pediatric Vaccines Sales (2010 - 2014) 6.5.1 Novartis - Influenza Pediatric Vaccines Sales 6.6 bioCSL (Now Seqirus) - Pediatric Vaccines Sales and Forecast (2010 - 2021) 6.6.1 bioCSL - Influenza Pediatric Vaccines Sales and Forecast 6.7 Medimmune (Subsidiary of AstraZeneca) - Pediatric Vaccines Sales and Forecast (2007 - 2021) 6.7.1 Medimmune - Influenza Pediatric Vaccines Sales and Forecast 7. Global Pediatric Vaccines Market - Regional Distribution (2010 - 2021) 7.1 United States - Pediatric Vaccines Market and Forecast 7.2 North America/Caribbean - Pediatric Vaccines Market and Forecast 7.3 South America - Pediatric Vaccines Market and Forecast 7.4 Europe - Pediatric Vaccines Market and Forecast 7.5 Japan - Pediatric Vaccines Market and Forecast 7.6 India - Pediatric Vaccines Market and Forecast 7.7 China - Pediatric Vaccines Market and Forecast 7.8 Rest of the World (ROW) - Pediatric Vaccines Market and Forecast 8. Major Vaccines Related Acquisitions (2005-2015) 9. Pediatric Vaccines Market - Driving Factors 9.1 GAVI Model Fuelling Vaccine Manufacturers 9.1.1 The Partnership Model 9.1.2 The Business Model 9.2 Global Immunization Vision and Strategy (GIVS) 9.3 Growing Vaccine Availability in United States 9.4 The Vaccine Injury Compensation Program 9.5 The Vaccine Safety Data link Project 9.6 Transformation of Vaccine Technologies 9.7 Global Vaccine Action Plan by WHO (2011 - 2020) 9.8 Continuous Focus on Effective Communication Strategies 10. Pediatric Vaccines Market - Challenges 10.1 Hurdles to Optimal use of Licensed Vaccines 10.1.1 Technical Obstacles 10.1.2 Economic obstacles 10.1.3 Cultural Obstacles 10.2 Shortening the Timeline for Vaccine Development 10.3 Complexity of Vaccine Development and Approval System Thwarts Product Development 10.3.1 Legal Obstacles 10.3.2 General Technical Barriers 10.3.3 Economic Barriers 10.3.4 Regulatory Barriers 10.4 Refusal/Resistance to Vaccination 10.5 Vaccine Adverse Event Reporting System 10.6 Vaccine Shortages and Delays 10.7 Obstacles in Vaccine Research and Development 10.8 Barriers to New Entrants in the Vaccines Market

List of Figures: Figure 2-1: Global - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 2-2: Global - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 3-1: Global Pediatric Vaccines - Disease Wise Market Share (Percent), 2010 - 2015 Figure 3-2: Global Pediatric Vaccines - Forecast for Disease Wise Market Share (Percent), 2016 - 2021 Figure 3-3: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share (Percent), 2010 - 2015 Figure 3-4: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021 Figure 3-5: Sanofi Pasteur - Pediatric Vaccines Sales Share (Percent), 2010 - 2015 Figure 3-6: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021 Figure 3-7: Merck - Pediatric Vaccines Sales Share (Percent), 2007 - 2015 Figure 3-8: Merck - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021 Figure 3-9: Pfizer - Pediatric Vaccines Sales Share and Forecast (Percent), 2015 - 2021 Figure 3-10: DTaP Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015 Figure 3-11: DTaP Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021 Figure 3-12: Hepatitis Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015 Figure 3-13: Hepatitis Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021 Figure 3-14: Meningococcal Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015 Figure 3-15: Meningococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021 Figure 3-16: Pneumococcal Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015 Figure 3-17: Pneumococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021 Figure 3-18: Rotavirus Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015 Figure 3-19: Rotavirus Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021 Figure 3-20: Tdap Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015 Figure 3-21: Tdap Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021 Figure 3-22: Influenza Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015 Figure 3-23: Influenza Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021 Figure 3-24: Region Wise - Pediatric Vaccines Market Share (Percent), 2010 - 2015 Figure 3-25: Region Wise - Forecast for Pediatric Vaccines Market Share (Percent), 2016 - 2021 Figure 4-1: DTaP - Pediatric Vaccines Market (Million US$), 2006 - 2015 Figure 4-2: DTaP - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-3: Polio - Pediatric Vaccines Market (Million US$), 2006 - 2015 Figure 4-4: Polio - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-5: Hepatitis - Pediatric Vaccines Market (Million US$), 2007 - 2015 Figure 4-6: Hepatitis - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-7: Influenza - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 4-8: Influenza - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-9: HPV - Pediatric Vaccines Market (Million US$), 2007 - 2015 Figure 4-10: HPV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-11: Pneumococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 4-12: Pneumococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-13: Meningococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 4-14: Meningococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-15: MMRV - Pediatric Vaccines Market (Million US$), 2007 - 2015 Figure 4-16: MMRV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-17: Rotavirus - Pediatric Vaccines Market (Million US$), 2006 - 2015 Figure 4-18: Rotavirus - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 4-19: Tdap - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 4-20: Tdap - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 5-1: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 5-2: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 5-3: Sanofi Pasteur - Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 5-4: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 5-5: Sanofi Pasteur - Pipeline Vaccines, April 2016 Figure 5-6: Merck - Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 5-7: Merck - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 5-8: Novartis - Pediatric Vaccines Sales (Million US$), 2010 - 2014 Figure 5-9: Pfizer - Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 5-10: Pfizer - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 5-11: bioCSL - Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 5-12: bioCSL - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 5-13: Medimmune - Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 5-14: Medimmune - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-1: GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-2: GlaxoSmithKline (GSK) - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-3: GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-4: GlaxoSmithKline (GSK) - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-5: GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-6: GlaxoSmithKline (GSK) - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-7: GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-8: GlaxoSmithKline (GSK) - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-9: GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-10: GlaxoSmithKline (GSK) - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-11: GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-12: GlaxoSmithKline (GSK) - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-13: Sanofi Pasteur - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-14: Sanofi Pasteur - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-15: Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-16: Sanofi Pasteur - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-17: Sanofi Pasteur - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-18: Sanofi Pasteur - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-19: Sanofi Pasteur - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-20: Sanofi Pasteur - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-21: Merck - Hepatitis Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 6-22: Merck - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-23: Merck - HPV Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 6-24: Merck - Forecast for HPV Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-25: Merck - MMRV Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 6-26: Merck - Forecast for MMRV Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-27: Merck - Pneumococcal Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 6-28: Merck - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-29: Merck - Rotavirus Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 6-30: Merck - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-31: Pfizer - Pneumococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-32: Pfizer - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-33: Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast (Million US$), 2015 - 2021 Figure 6-34: Novartis - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2014 Figure 6-35: bioCSL - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015 Figure 6-36: bioCSL - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 6-37: Medimmune - Influenza Pediatric Vaccines Sales (Million US$), 2007 - 2015 Figure 6-38: Medimmune - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021 Figure 7-1: United States - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-2: United States - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 7-3: North America/Caribbean - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-4: North America/Caribbean - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 7-5: South America - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-6: South America - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 7-7: Europe - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-8: Europe - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 7-9: Japan - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-10: Japan - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 7-11: India - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-12: India - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 7-13: China - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-14: China - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 7-15: ROW - Pediatric Vaccines Market (Million US$), 2010 - 2015 Figure 7-16: ROW - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021 Figure 9-1: US - Number of Retail Clinics offering Vaccination (Number), 2007 - 2012 List of Tables: Table 3-1: Global Pediatric Vaccines - Company Wise Market Share (Percent), 2010 - 2015 Table 3-2: Global Pediatric Vaccines - Forecast for Company Wise Market Share (Percent), 2016 - 2021 Table 8-1: Worldwide - Major Vaccine Related Acquisitions, (2005 - 2015) Table 9-1: Global - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020 Table 9-2: Global Goal-Level Indicators, 2015 & 2020 Table 9-3: Improvement Strategies or Requirements - the Joint Commission and the Projects Collaborating Organizations

GlaxoSmithKline, Sanofi Pasteur, Merck, Novartis, Pfizer, bioCSL, Medimmune